Judge Axes Cell Analysis Patent In Case Against Parse - Law360

By Editorial Team

A federal magistrate judge in Delaware has trimmed a suit accusing biotechnology company Parse Biosciences of infringing patents covering a way of detecting target molecules in cell samples, finding one of the patents was invalid.

The judge ruled that the patent titled "Kit for split-pool barcoding target molecules that are in or on cells or cell organelles" was invalid, impacting the case against Parse Biosciences.

The case involves several patents related to methods of identifying multiple epitopes in cells, including patents numbered 10,626,442, 10,982,256, and 11,512,341.

Law360 is a leading source of legal news and analysis, offering subscribers access to daily newsletters, expert analysis, real-time alerts, and a vast archive of articles across various legal topics and industries.

For more information and detailed case documents, interested parties can refer to the attached opinion and related sections detailing the case information, law firms involved, and the companies at the center of the dispute.